Related Experiment Video
Updated: Jan 3, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Improving Recognition and Reporting of Adverse Drug Reactions in the NICU: A Quality Improvement Project
Betsy Cammack1, Alexandra Oschman2, Tamorah Lewis1,3
1Children's Mercy Hospital, Department of Pediatrics, Division of Neonatology, Kansas City, MO.
Insights
Adverse drug reactions (ADRs) in the Neonatal Intensive Care Unit (NICU) are often missed. A bedside tool improved ADR detection and the Du score better characterized neonatal ADRs compared to the Naranjo score.
Area of Science:
- Neonatal Intensive Care Unit (NICU) research
- Pharmacovigilance
- Quality Improvement in Healthcare
Background:
- Adverse drug reactions (ADRs) are significantly under-recognized and under-reported in Neonatal Intensive Care Units (NICUs).
- Pediatric patients face a higher risk of ADRs compared to non-elderly adults, highlighting a critical need for improved monitoring.
- The Children's Mercy NICU reported a 0.29% ADR rate in 2015, indicating substantial room for improvement in detection and characterization.
Purpose of the Study:
- To implement a quality improvement project to increase the daily assessment of patients for ADRs.
- To evaluate the effectiveness of a bedside monitoring tool in improving ADR recognition and reporting in the NICU.
- To compare the utility of the Naranjo score versus the neonatal-specific Du score for characterizing ADRs in neonates.
Main Methods:
- A quality improvement project focused on daily ADR assessment for patients receiving specific high-risk medications (indomethacin, dexmedetomidine, fentanyl, lorazepam, dexamethasone, hydrocortisone).
- Utilized Plan-Do-Study-Act (PDSA) cycles over one year to implement and refine a bedside monitoring tool.
- Calculated Naranjo and Du scores for recognized ADRs to compare their effectiveness in characterizing events.
Main Results:
- The bedside monitoring tool was used 83% of the time, significantly increasing the identification of potential ADRs (28 events).
- Three PDSA cycles were completed within one year, demonstrating iterative improvement in the process.
- The Du score showed greater appropriateness for characterizing neonatal ADRs compared to the Naranjo score.
Conclusions:
- A bedside monitoring tool effectively enhances ADR detection rates in the NICU setting.
- Challenges were encountered in consistently identifying target patients and ensuring tool accessibility at the bedside.
- The Du score is a more suitable tool for classifying ADRs in neonates than the Naranjo score.
Abstract:
Adverse drug reactions (ADRs) are under-recognized and under-reported in the Neonatal Intensive Care Unit (NICU) population, with up to 95% of all ADRs not reported. Compared with non-elderly adults, pediatric patients are 3 times more likely to experience an ADR, with varying rates from 0.6% to 16.8%. The Children's Mercy NICU has an ADR rate of 0.29% (2015). This high rate presents an opportunity to increase recognition and reporting, and improve characterization of ADRs in the NICU.
Methods:
The primary aim of this quality improvement project was for 70% of patients who received specified medications (indomethacin, dexmedetomidine, fentanyl, lorazepam, dexamethasone, or hydrocortisone) in the first 3 months of age to be assessed daily for ADRs. We selected these medications due to the frequency of use and well-understood ADR associations. For each ADR recognized, the Naranjo score, was calculated and compared with the neonatal-specific Du score to assess the effectiveness of ADR characterization.
Results:
Implementation occurred on May 15, 2017. We completed 3 PDSA cycles over 1 year. The bedside monitoring tool was utilized 83% of the time. Twenty-eight potential ADRs were identified, far exceeding the number reported before implementation. The Du score appeared to better characterize ADRs compared with the Naranjo score.
Conclusions:
Use of a bedside monitoring tool improves ADR detection. We experienced challenges with consistently identifying patients on target drugs and getting the tool to the bedside. Application of the Du score for ADR classification in neonates appears to be more appropriate than the use of the Naranjo.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Nursing Clinical Information System
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Drug Regulation
Factors Affecting Drug Response: Overview

